Figures & data
Figure 1 X-ray powder diffraction pattern of lyophilized nanocrystalline cellulose. Intense peaks at 15° and 23° 2θ, due to constructive interference of diffracted x-rays, in addition to the lack of an amorphous halo, indicate the highly crystalline nature of the material.
![Figure 1 X-ray powder diffraction pattern of lyophilized nanocrystalline cellulose. Intense peaks at 15° and 23° 2θ, due to constructive interference of diffracted x-rays, in addition to the lack of an amorphous halo, indicate the highly crystalline nature of the material.](/cms/asset/b1efe50d-f28f-42d6-8bba-ecee5e3d0755/dijn_a_16749_f0001_c.jpg)
Figure 2 Scanning electron micrograph of a dried film of nanocrystalline cellulose (NCC) (A) and NCC crystallites in deionized distilled water (B).
![Figure 2 Scanning electron micrograph of a dried film of nanocrystalline cellulose (NCC) (A) and NCC crystallites in deionized distilled water (B).](/cms/asset/8a4acf5e-3b27-4b1d-a522-2f602274463e/dijn_a_16749_f0002_b.jpg)
Figure 3 The binding of doxorubicin to 2 mg NCC in 10 mM, pH 7.4 phosphate buffered saline at 25°C (A) and deionized distilled water at 25°C (B).
Abbreviation: NCC, nanocrystalline cellulose.
![Figure 3 The binding of doxorubicin to 2 mg NCC in 10 mM, pH 7.4 phosphate buffered saline at 25°C (A) and deionized distilled water at 25°C (B).Abbreviation: NCC, nanocrystalline cellulose.](/cms/asset/af7f21c0-61bc-437b-9272-ef082446c6f9/dijn_a_16749_f0003_b.jpg)
Figure 4 The binding of tetracycline to 2 mg NCC in 10 mM, pH 7.4 phosphate buffered saline at 25°C (A) or deionized distilled water at 25°C (B).
Abbreviation: NCC, nanocrystalline cellulose.
![Figure 4 The binding of tetracycline to 2 mg NCC in 10 mM, pH 7.4 phosphate buffered saline at 25°C (A) or deionized distilled water at 25°C (B).Abbreviation: NCC, nanocrystalline cellulose.](/cms/asset/23b598d5-f49a-4149-b3b8-8ff160d1c751/dijn_a_16749_f0004_b.jpg)
Figure 5 A) The binding of docetaxel to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.755 mM (▴), 1.51 mM (▾), 2.27 mM (♦), 4.53 mM (•), 6.79 mM (□), and 12.9 mM (Δ). B) Maximal binding of docetaxel at a CTAB concentration of 12.9 mM.
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 5 A) The binding of docetaxel to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.755 mM (▴), 1.51 mM (▾), 2.27 mM (♦), 4.53 mM (•), 6.79 mM (□), and 12.9 mM (Δ). B) Maximal binding of docetaxel at a CTAB concentration of 12.9 mM.Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/84108cef-70cc-487a-b56b-6112bc256956/dijn_a_16749_f0005_b.jpg)
Figure 6 A) The binding of paclitaxel to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.755 mM (▴), 1.51 mM (▾), 2.27 mM (♦), 4.53 mM (•), 6.79 mM (□), and 12.9 mM (Δ). B) Maximal binding of paclitaxel at a CTAB concentration of 12.9 mM.
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 6 A) The binding of paclitaxel to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.755 mM (▴), 1.51 mM (▾), 2.27 mM (♦), 4.53 mM (•), 6.79 mM (□), and 12.9 mM (Δ). B) Maximal binding of paclitaxel at a CTAB concentration of 12.9 mM.Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/2ec3a3a7-71be-413e-a87e-28ee941f9ced/dijn_a_16749_f0006_b.jpg)
Figure 7 The binding of etoposide to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.375 mM (▴), 0.755 mM (▾), 1.51 mM (♦), 2.27 mM (•), 4.53 mM (□), and 6.79 mM (Δ), and 12.9 (∇).
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 7 The binding of etoposide to 2.5 mg of NCC/CTAB nanocomplexes in 10 mM NaCl at 25°C with CTAB concentrations of 0 mM (▪), 0.375 mM (▴), 0.755 mM (▾), 1.51 mM (♦), 2.27 mM (•), 4.53 mM (□), and 6.79 mM (Δ), and 12.9 (∇).Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/4e7c4505-1573-43fd-a299-b6d653b0cefc/dijn_a_16749_f0007_b.jpg)
Figure 8 The in vitro release of doxorubicin (Δ) and tetracycline (□) from nanocrystalline cellulose in 10 mM phosphate buffered saline at 37°C.
![Figure 8 The in vitro release of doxorubicin (Δ) and tetracycline (□) from nanocrystalline cellulose in 10 mM phosphate buffered saline at 37°C.](/cms/asset/fabbf5f8-c813-424c-ad9e-a745114ae21d/dijn_a_16749_f0008_b.jpg)
Figure 9 The in vitro release of etoposide (∇), docetaxel (□), and paclitaxel (Δ) from NCC/CTAB nanocomplexes with 12.9 mM CTAB in 10 mM phosphate buffered saline at 37°C.
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 9 The in vitro release of etoposide (∇), docetaxel (□), and paclitaxel (Δ) from NCC/CTAB nanocomplexes with 12.9 mM CTAB in 10 mM phosphate buffered saline at 37°C.Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/4e6a8e72-32f1-47f3-8504-34f029a97d01/dijn_a_16749_f0009_b.jpg)
Figure 10 Zeta potential of NCC/CTAB nanocomplexes as a function of CTAB concentration.
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 10 Zeta potential of NCC/CTAB nanocomplexes as a function of CTAB concentration.Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/11a8d04c-ac2f-426a-a33e-817d770a1eb3/dijn_a_16749_f0010_b.jpg)
Figure 11 Mass of NCC/CTAB/fluorescein bound to KU-7 cells as a function of concentration of NCC/CTAB/fluorescein added to cells.
Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.
![Figure 11 Mass of NCC/CTAB/fluorescein bound to KU-7 cells as a function of concentration of NCC/CTAB/fluorescein added to cells.Abbreviations: CTAB, cetyl trimethylammonium bromide; NCC, nanocrystalline cellulose.](/cms/asset/57ec0201-74b3-457f-a6d8-f1e1f438907a/dijn_a_16749_f0011_b.jpg)
Figure 12 Confocal micrographs of KU-7 cells incubated for 2 hours with NCC/CTAB/fluorescein nanocomplexes with a NCC/CTAB/fluorescein concentration of 0.25 mg/mL. A) White light image of KU-7 cells. B) Staining of the nuclei with DAPI. C) Fluorescein in the cytoplasm. D) An overlay of images B and C.
Abbreviations: CTAB, cetyl trimethylammonium bromide; DAPI, 4′,6-diamidino-2-phenylindole; NCC, nanocrystalline cellulose.
![Figure 12 Confocal micrographs of KU-7 cells incubated for 2 hours with NCC/CTAB/fluorescein nanocomplexes with a NCC/CTAB/fluorescein concentration of 0.25 mg/mL. A) White light image of KU-7 cells. B) Staining of the nuclei with DAPI. C) Fluorescein in the cytoplasm. D) An overlay of images B and C.Abbreviations: CTAB, cetyl trimethylammonium bromide; DAPI, 4′,6-diamidino-2-phenylindole; NCC, nanocrystalline cellulose.](/cms/asset/c470a540-93c6-4cc6-84ca-d0b7d4c2f60e/dijn_a_16749_f0012_c.jpg)